Product Images Levomilnacipran

This is a drug interaction report that lists the effects of various drugs on the liver metabolism. The report provides information on the impact of CYP3A4 inhibitors like ketoconazole, CYP3A4 inducers like carbamazepine, and CYP3A4 substrates like alprazolam on the liver's metabolism. It also shows the fold change and confidence intervals in percentage (%) and graphical representation, relative to the reference, which indicates the impact of drugs on liver metabolism.*

This is a table with population description that includes age, gender, and levels of renal and hepatic impairment. There are also columns related to PK (pharmacokinetics) parameters such as Cmax and AUC, and the table ends with a section on fold change and 90% confidence interval relative to reference. No specific context or drug/therapy is provided.*

This is a description of a medication with the NDC code 65162-411-03. Each capsule contains 20 mg of levomilnacipran, which is equivalent to 23 mg of levomilnacipran hydrochloride. The usual dosage can be found in the full prescribing information. The capsules should be swallowed whole and not chewed or crushed. They should be stored between 20°C to 25°C (68°F to 77°F) with excursions permitted between 15°C to 30°C (59°F to 86°F). It is important to keep this medication out of reach of children. The medication is manufactured by Amneal Pharmaceuticals Pvt. Ltd in Ahmedabad, India, and distributed by Amneal Pharmaceuticals LLC in Bridgewater, NJ.*

This is a description of a medication called Levomilnacipran, which comes in capsule form. Each capsule contains 45.9mg of Levomilnacipran hydrochloride. It is important to swallow the capsule whole and not to chew or crush it. The medication should be stored at 20-25°C (68-77°F) and kept out of reach of children. The manufacturer is Amneal Pharmaceuticals Pvt. Ltd. located in Ahmedabad, India, and it is distributed by Amneal Pharmaceuticals LLC in Bridgewater, NJ. Specific dosage instructions are available in the full prescribing information.*

This is a description of Levomilnacipran, a medication that comes in the form of extended-release capsules, with each containing 91.8mg of Levomilnacipran hydrochloride. The medication guide advises that it must be taken as directed and whole, without chewing or crushing. The medication must be stored in a dry, cool place following the instructions given. The prescription must be dispensed only by a pharmacist with the accompanying Rx and the patient must keep it out of children's reach. Amneal Pharmaceuticals LLC is the distributor, and the medication is manufactured by Amneal Pharmaceuticals Put. Ltd. in India.*

NDC 65162-455-03 is a medication in capsule form containing 120mg of Levomilnacipran. It should be swallowed whole and not chewed or crushed. The extended-release capsules should be stored between 20-25°C (68-77°F) with limited excursions of 15-30°C (59-86°F). Amneal Pharmaceuticals is the manufacturer and distributor of this medication. A pharmacist should only dispense this medication with an accompanying prescription and medication guide. Keep this and all medication out of the reach of children.*